Synthesis and TGF-β receptor binding inhibition of multibranched compounds

被引:1
作者
Subra, Gilles
Amblard, Muriel
Verdie, Pascal
Komesli, Sylviane
Dutartre, Patrick
Durand, Philippe
Renaut, Patrice
Martinez, Jean
机构
[1] Univ Montpellier 1, Lab Aminoacides Peptides & Prot, CNRS, UMR 5810,Fac Pharm, F-34000 Montpellier, France
[2] Labs Fournier, F-21121 Daix, France
来源
QSAR & COMBINATORIAL SCIENCE | 2007年 / 26卷 / 04期
关键词
dimer; peptide; solid phase synthesis; TGF-beta;
D O I
10.1002/qsar.200520134
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
As a part of our project aiming at the discovery of novel synthetic ligands of Transforming Growth Factor Beta (TGF-beta) receptors, five libraries were sequentially synthesised and screened. The biological mechanism involved in the TGF-beta signal transduction proceeds through the hetero-oligomerisation of two TGF-beta subreceptor dimers, Transforming growth factor Beta Receptors (T beta R)-I and II. We hypothesised that synthetic dimers and multibranched-molecules could mimic the natural hormone action by closing the receptor subunits. Mimotope multipin technology was used to synthesise libraries of dimers and tetramers on solid support. This strategy led to the discovery of one of the most potent TGF-beta receptor ligand on type II TGF-beta receptor, described in the literature today.
引用
收藏
页码:496 / 510
页数:15
相关论文
共 15 条
  • [1] SYNTHESIS OF A SYMMETRICALLY BRANCH TEMPLATE FOR PARALLEL ALPHA-HELIX DIMERS
    BAMBINO, F
    BROWNLEE, RTC
    CHIU, FCK
    [J]. TETRAHEDRON LETTERS, 1994, 35 (26) : 4619 - 4622
  • [3] DESIGN, SYNTHESIS, AND IN-VITRO ACTIVITY OF BIS(SUCCINIMIDO)HEXANE PEPTIDE HETERODIMERS WITH COMBINED B-1 AND B-2 ANTAGONIST ACTIVITY
    CHERONIS, JC
    WHALLEY, ET
    ALLEN, LG
    LOY, SD
    ELDER, MW
    DUGGAN, MJ
    GROSS, KL
    BLODGETT, JK
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (03) : 348 - 355
  • [4] CORNISHBOWDEN A, 1984, EUR J BIOCHEM, V138, P9, DOI 10.1111/j.1432-1033.1984.tb07877.x
  • [5] Daffix I, 1998, J PEPT RES, V52, P1
  • [6] Erythropoietin mimetics derived from solution phase combinatorial libraries
    Goldberg, J
    Jin, Q
    Ambroise, Y
    Satoh, S
    Desharnais, J
    Capps, K
    Boger, DL
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2002, 124 (04) : 544 - 555
  • [7] G-protein coupled receptors bivalent ligands and drug design
    Halazy, S
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 1999, 9 (04) : 431 - 446
  • [8] Serotonin dimers: Application of the bivalent ligand approach to the design of new potent and selective 5-HT1B/1D agonists
    Halazy, S
    Perez, M
    Fourrier, C
    Pallard, I
    Pauwels, PJ
    Palmier, C
    John, GW
    Valentin, JP
    Bonnafous, R
    Martinez, J
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (25) : 4920 - 4927
  • [9] DIMERIC SUBSTANCE-P ANALOG SHOWS A HIGHLY POTENT ACTIVITY OF THE INVIVO SALIVARY SECRETION IN THE RAT
    HIGUCHI, Y
    TAKANO, Y
    SHIMAZAKI, H
    SHIMOHIGASHI, Y
    KODAMA, H
    MATSUMOTO, H
    SAKAGUCHI, K
    NONAKA, S
    SAITO, R
    WAKI, M
    KAMIYA, H
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 160 (03) : 413 - 416
  • [10] Amino-terminal dimerization of an erythropoietin mimetic peptide results in increased erythropoietic activity
    Johnson, DL
    Farrell, FX
    Barbone, FP
    McMahon, FJ
    Tullai, J
    Kroon, D
    Freedy, J
    Zivin, RA
    Mulcahy, LS
    Jolliffe, LK
    [J]. CHEMISTRY & BIOLOGY, 1997, 4 (12): : 939 - 950